EPRX NASDAQ
Eupraxia Pharmaceuticals Inc.
1W: -9.6%
1M: -2.8%
3M: +11.0%
YTD: -4.4%
1Y: +19.3%
$7.24
-0.59 (-7.54%)
Weekly Expected Move ±12.5%
$5
$6
$7
$8
$9
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$118M
+237.7% ▲
5Y CAGR: +140.9%
Total Liabilities
$8M
+151.7% ▲
5Y CAGR: -19.5%
Shareholders Equity
$112M
+236.4% ▲
Cash & Investments
$110M
+233.3% ▲
5Y CAGR: +274.3%
Total Debt
$211K
+194.2% ▲
5Y CAGR: -56.0%
Net Debt
-$110M
-233.4% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $21M | $25M | $19M | $33M | $110M |
| Short-Term Investments | $9M | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $30M | $25M | $19M | $33M | $110M |
| Net Receivables | $0 | $0 | $191K | $229K | $923K |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $430K | $121K | $0 | $0 | $1M |
| Total Current Assets | $31M | $25M | $20M | $34M | $117M |
| Property, Plant & Equip. | $589K | $719K | $456K | $425K | $1M |
| Goodwill & Intangibles | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $31K | $3K | $7K | $81K | $88K |
| Total Non-Current Assets | $620K | $722K | $463K | $506K | $1M |
| Total Assets | $31M | $26M | $20M | $35M | $118M |
| — Liabilities — | |||||
| Accounts Payable | $0 | $0 | $0 | $0 | $0 |
| Short-Term Debt | $95K | $108K | $10M | $0 | $107K |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $5K | $22K | $859K | $1M | $5M |
| Total Current Liabilities | $2M | $4M | $19M | $3M | $8M |
| Long-Term Debt | $10M | $12M | $0 | $0 | $0 |
| Other Non-Current Liab. | -$0 | -$0 | $0 | $0 | $0 |
| Total Non-Current Liabilities | $10M | $12M | $0 | $0 | $104K |
| Total Liabilities | $12M | $16M | $19M | $3M | $8M |
| — Equity — | |||||
| Common Stock | $78M | $96M | $93M | $116M | $268M |
| Retained Earnings | -$74M | -$105M | -$106M | -$131M | -$232M |
| Accumulated OCI | $17M | -$4M | -$3M | -$4M | -$3M |
| Total Stockholders Equity | $20M | $11M | $2M | $33M | $112M |
| Total Liabilities & Equity | $31M | $26M | $20M | $35M | $118M |
| — Key Metrics — | |||||
| Total Debt | $10M | $12M | $10M | $72K | $211K |
| Net Debt | -$11M | -$13M | -$9M | -$33M | -$110M |
| Total Investments | $9M | $0 | $0 | $0 | $0 |